All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Racing ahead of Congress, the Centers for Medicare & Medicaid Services (CMS) withdrew parts of a controversial rule revising the Medicare Part D prescription drug program.
